Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Availability and Funding of Clinical Genomic Sequencing Globally

Phillips KA. et al, (2021), BMJ Global Health

Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom

BUCHANAN J. et al, (2021), Applied Health Economics and Health Policy

Implementing interventions to reduce antibiotic use: A qualitative study in high-prescribing practices

BOREK A. et al, (2021), BMC Family Practice

FINANCING AND REIMBURSEMENT FOR PERSONALISED MEDICINE - ARE WE THERE YET?

Koleva-Kolarova R. et al, (2020), VALUE IN HEALTH, 23, S756 - S756

Effectiveness, cost-effectiveness and safety of gabapentin versus placebo as an adjunct to multimodal pain regimens in surgical patients: protocol of a placebo controlled randomised controlled trial with blinding (GAP study).

Baos S. et al, (2020), BMJ Open, 10

Awareness of appropriate antibiotic use in primary care for influenza-like illness: evidence of improvement from UK population-based surveys

POUWELS K. et al, (2020), Antibiotics

Randomized Trial of the i-gel Supraglottic Airway Device Versus Tracheal Intubation During Out of Hospital Cardiac Arrest (AIRWAYS-2): Patient Outcomes at Three and Six Months.

Benger JR. et al, (2020), Resuscitation

Delayed antibiotic prescription by general practitioners in the UK: a stated-choice study

MORRELL E. et al, (2020), Antibiotics

The Melanoma Genomics Managing Your Risk Study randomised controlled trial: statistical analysis plan.

Lo SN. et al, (2020), Trials, 21

How did a Quality Premium financial incentive influence antibiotic prescribing in primary care? Views of Clinical Commissioning Group and general practice professionals

BOREK A. et al, (2020), Journal of Antimicrobial Chemotherapy

Health Technology Appraisal and Access to Cancer Drugs in the UK

MORRELL E., (2020)

Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey

ROOPE L. et al, (2020), BMC Medicine

Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling

Marshall DA. et al, (2020), Value in Health

Implications of secondary findings for clinical contexts

MORRISON M. et al, (2020), Secondary Findings in Genomic Research, 155 - 201

Reducing expectations for antibiotics in primary care: a randomised experiment to test the response to fear based messages about antimicrobial resistance

ROOPE L. et al, (2020), BMC Medicine

Estimating the effect of healthcare-associated infections on excess length of hospital stay using inverse-probability weighted survival curves

Pouwels KB. et al, (2020), Clinical Infectious Diseases

Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised study.

Lau D. et al, (2020), ESMO Open, 5

Content of Health Economics Analysis Plans (HEAPs) for Trial-Based Economic Evaluations: Expert Delphi Consensus Survey

Thorn JC. et al, (2020), Value in Health

Essential items for a Health Economics Analysis Plan (HEAP): expert Delphi consensus survey

Thorn J. et al, (2019), TRIALS, 20

A review of health economic studies comparing traditional and massively parallel sequencing diagnostic pathways for suspected genetic disorders

Fahr P. et al, (2019), PharmacoEconomics

Load More

Handbooks in Health Economic Evaluation

A series published by Oxford University Press.

Find out more